The Food and Drug Administration on Thursday announced that CBD products, increasingly popular but largely unregulated, will soon join the ranks of other more mainstream, regulated products.
But rather than regulate the product as a dietary supplement or food, the agency announced it will work with Congress to create a new regulatory pathway for CBD products.
The announcement came as the agency has faced some pressure to regulate CBD products as dietary supplements. As part of the announcement, the agency said it was denying three citizen petitions that had asked for FDA rule-making to allow the marketing of CBD products as dietary supplements — an idea that had gained some traction on Capitol Hill.
